Lawsuit filed against Lonza, the Dutch manufacturer of the world's first CRISPR-based genome editing therapy, CASGEVY Second European action following UK litigation, enforcing ToolGen's rights to fundamental CRISPR-Cas9 RNP technology
Share This Blog
Ready-to-post copy includes the blog link.
ToolGen Files Patent Infringement Lawsuit Against Lonza in the Netherlands Lawsuit filed against Lonza, the Dutch manufacturer of the world's first CRISPR-based genome editing therapy, CASGEVY Second European action following UK litigation, enforcing ToolGen's rights to fundamental CRISPR-Cas9... Read the full IIPLA blog post: https://iipla.org/blog/toolgen-files-patent-infringement-lawsuit-against-lonza-in-the-netherlands